Tag: RNA

June 28, 2018

Translate Bio Announces Pricing of Initial Public Offering

Translate Bio (Nasdaq:TBIO) a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat...
May 9, 2018

miRagen Therapeutics Announces New Interim Data From Phase 1 Clinical Trial of Cobomarsen in Mycosis Fungoides

miRagen Therapeutics (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced new interim data...
April 16, 2018

Cancer Genetics’ Unique Tissue of Origin Test Receives Special FDA 510(k) Clearance

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that it...
April 12, 2018

Illumina and Loxo Oncology Form Collaboration, Share Prices Increase

Illumina and Loxo have teamed up to develop and commercialize a multi-gene panel for broad tumor profiling for cancer indications.
March 28, 2018

Arcturus Therapeutics Initiates Lawsuit Against Joseph E. Payne to Protect the Interests of Arcturus Shareholders

Arcturus Therapeutics (NASDAQ:ARCT), a leading RNA medicines company, today initiated a lawsuit in San Diego Superior Court against former President...
March 27, 2018

miRagen Announces Initiation of Phase 1 Clinical Trial of MRG-110

miRagen Therapeutics (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today the initiation...
March 15, 2018

miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

miRagen Therapeutics (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today reported fourth quarter...